COPD epidemiology

Amegadzie, J. E., Gao, Z., Quint, J. K., Russell, R., Hurst, J. R., . Y. Lee, T., et al. (2023). QRISK3 underestimates the risk of cardiovascular events in patients with COPD. Thorax.
Whittaker, H., Rothnie, K. J., & Quint, J. K. (2023). Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England. Thorax.
Lenoir, A., Whittaker, H., Gayle, A., Jarvis, D., & Quint, J. K. (2022). Mortality in non-exacerbating COPD: a longitudinal analysis of UK primary care data. Thorax.
Whittaker, H., Nordon, C., Rubino, A., Morris, T., Xu, Y., de Nigris, E., et al. (2022). Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study. Thorax.
Czira, A., Banks, V., Requena, G., Wood, R., Tritton, T., Wild, R., et al. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. Bmj Open Respir Res, 9.
Whittaker, H., Van Ganse, E., Dalon, F., Nolin, M., Marrant-Micallef, C., Pison, C., et al. (2022). Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. Bmj Open Respir Res, 9.